Symrise AG, a global leader in nutrition solutions, has entered a strategic partnership with Hofseth BioCare ASA (HBC), a Norwegian manufacturer of salmon-based ingredients, to expand its presence in the human and pet nutrition markets. The collaboration aims to complement Symrise’s existing portfolio by incorporating clinically proven marine ingredients and to accelerate HBC’s market reach and scale, said the company.
HBC plans to refurbish its Berkak facility into a state-of-the-art enzymatic hydrolysis plant that will triple its production capacity, while both companies explore new product developments and leverage Symrise’s established market channels to promote HBC products globally.
"This partnership with HBC is testament to their unique footprint and differentiated science," said Dr. Jean-Yves Parisot, CEO of Symrise AG. "Their investments in clinical studies demonstrate proven benefits in key categories of metabolic health, immune health, gut health and mobility, setting them apart. This partnership is well aligned with our willingness to accelerate in health in the context of our 'One Care' journey but also with the recent creation of the Global Marine Platform to explore the vast potential that the oceans could offer us."
According to HBC, sustainability is deeply embedded in its DNA. HBC has developed a unique proprietary technology to upcycle fresh salmon offcuts not used in the production of fillets into bioactive ingredients with demonstrated health benefits. The collaboration between HBC and Symrise will enhance the public awareness of the health value of marine ingredients and will further help position HBC as a leader in science-led marine nutrition globally, said Jon Olav Ødegård, CEO of HBC.
"Symrise has been a key partner for us already," he added. "The human health and premium pet markets continue to grow very strongly, and this partnership will allow us to sustain our growth trajectory and position us as the leading player in the science-led marine nutrition segment dedicated to human health."
Adapted from a press release.
